Name: UMIN ID:
Unique ID issued by UMIN | UMIN000009734 |
---|---|
Receipt number | R000011411 |
Scientific Title | Feasibility study of combination therapy with S-1 plus irinotecan in patients with EGFR positive KRAS mutation type unresectable colorectal cancer, who had previously received on irinotecan, oxaliplatin and fluoropyrimidine, bevacizumab |
Date of disclosure of the study information | 2013/01/14 |
Last modified on | 2022/01/17 07:41:08 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2013/01/09 12:06:38 | ||
2 | Update | 2022/01/17 07:41:08 | Date of IRB Last follow-up date Date of closure to data entry Date trial data considered complete Date analysis concluded Other related information |